about
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypesAutoinflammatory gene mutations in Behçet's diseaseHome infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupPharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.Autoinflammatory diseases: a possible cause of thrombosis?Familial Mediterranean Fever: a review for clinical management.A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.Polymyalgia rheumatica in 2011.Familial Mediterranean fever: new phenotypes.IL-1β biological treatment of familial Mediterranean fever.Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study.Association of retroperitoneal fibrosis, proctitis and rectal stenosis.Early diagnosis and stage-adapted treatment of Wegener's granulomatosis.The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.Fecal calprotectin in first-degree relatives of patients with ulcerative colitis.Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients.Tolerance induction to rofecoxib in a patient with Bartter's syndrome.FMF revisited.Folic acid supplementation during methotrexate treatment: nonsense?Human papillomavirus vaccine and systemic lupus erythematosus.Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever.Non-life-threatening sepsis: report of two cases.Anti-endothelial autoantibodies in patients with sudden hearing loss.Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene.Decreased insulin binding to red blood cells in liver cirrhosis.Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ.Scleroderma and liver disease: a case of an association with primary sclerosing cholangitis.A position for tumor necrosis factor inhibitors in the management of colchicine-resistant familial Mediterranean fever?PFAPA syndrome as an hereditary autoinflamatory disorder.Colchicine trial in PFAPA Syndrome and MEFV-negative patients.Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study.Effect of fenfluramine on insulin/growth hormone ratio in obese subjectsEffect of fenfluramine on growth hormone and prolactin secretion in obese subjectsBehavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucoseInsulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusionChronic active hepatitis and Behçet's syndrome
P50
Q24329184-55259342-5CF1-4D41-9CD1-79B046A0C776Q24674998-87477070-2520-44D7-AF32-8213B44D9E02Q33835524-CD2A6683-1F5A-4CBD-BFC8-73A53A445A49Q34395824-A3191A94-4F67-43F9-ADB9-02B20866595AQ35595614-74BEEDAB-3708-409D-A1D9-9D0CE8371CA9Q37353389-3ABB422B-99C7-4440-99E7-D16D603264CBQ37361075-D48D23D2-34C6-48DC-9BE0-A1D6386E262BQ37994273-5890380E-3DDA-4709-91F6-5744C7DF3011Q38033405-B5EA4C89-5566-40D3-B8B3-921EE38B3C29Q38074355-68D9166B-35A1-42BD-9096-84961CAAFF7DQ38703626-9408883F-1E3C-42D2-97AD-799069D889D9Q39030930-1DCF1A4F-458B-4C78-ABBB-A64829738CC4Q39105783-546413E4-12B2-4D30-B0AA-BB3661008374Q39396829-2D604FC7-68F2-4733-84B5-42687DFF7D86Q40109719-3A5FBB22-D958-46CF-B8FE-4576AF4C6546Q41735494-9482F688-7396-4B3E-B779-8496E2081529Q44103686-F74B0B36-19D7-4A8C-87BE-F8E827911B3CQ44815205-2C2DFC2C-1AC2-4F5E-A6A5-C79D1712DCA9Q44924035-03898571-42EB-4C6E-B511-9522DBAB9971Q45175773-C01212D8-A777-4851-8C3B-C357C66AD7FBQ45229001-93585AE6-7AFF-478B-8018-6D53EE88CD4AQ45841999-B7C706E8-E52C-49EB-A9E1-1E4D653C0300Q46813066-D51D5707-47F2-471C-9E02-D905A27428C9Q46879131-F5CE36DD-16DD-4FB7-B27C-F3637C9F28B1Q47644779-10BF96AB-0DCA-478B-BD13-FFD9BC816BB2Q49181430-6F4BD425-4CEF-4119-83F6-B4A754CB8ADDQ50500521-BA2C2409-D144-4355-92F1-D889F3E40201Q51471726-7F9AB792-FD5C-4FF2-B371-909CE6CA9A15Q51646516-7FE25A7C-2B75-4B2C-9291-9B628C3A36B9Q52687414-78E7C4DE-9ED0-444B-8D01-5C581F553BEDQ53236335-6DDC9C85-786A-4FEF-8E6A-05BFF5198E3FQ53757309-6897BE43-3F32-4CB5-B9BA-C987C7836802Q54599753-810C9D80-7376-443B-B792-CE0A1AC11087Q54866402-5D3A432D-7365-4D03-9D52-51239F875E9DQ64882272-0132BD29-8DD6-49EC-B043-453DBFDD324AQ68131306-7B5F065E-2B4E-428B-A7D8-120CC5A766B8Q68671861-0D018411-7FE3-4BC0-B971-35728FE4C821Q68913480-79BAE792-A47A-4C8A-9EF2-2AA90C44000DQ69263746-3787A538-E89A-4699-AC0A-C83A2874055EQ70086067-9104A753-2228-44A0-B97C-A3FEE0BD55E4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Raffaele Manna
@ast
Raffaele Manna
@en
Raffaele Manna
@es
Raffaele Manna
@nl
Raffaele Manna
@sl
type
label
Raffaele Manna
@ast
Raffaele Manna
@en
Raffaele Manna
@es
Raffaele Manna
@nl
Raffaele Manna
@sl
prefLabel
Raffaele Manna
@ast
Raffaele Manna
@en
Raffaele Manna
@es
Raffaele Manna
@nl
Raffaele Manna
@sl
P106
P1153
7004911458
P21
P31
P496
0000-0003-1560-3907